A
Acclarent
Biotech & Life Sciences · Menlo Park, United States · Founded 2004
New technologies to treat patients suffering from ent disorders MoreLess
Acclarent, a subsidiary of Johnson & Johnson Medical Devices Companies, specializes in developing minimally invasive ear, nose, and throat (ENT) solutions. The company primarily serves healthcare providers, including hospitals and specialized ENT clinics, by offering advanced medical devices designed to improve patient outcomes and streamline surgical procedures. Operating within the medical device industry, Acclarent focuses on innovation and the integration of cutting-edge technology to address common ENT issues such as chronic sinusitis and Eustachian tube dysfunction. The business model revolves around the research, development, and commercialization of these specialized devices, generating revenue through the sale of its products to medical institutions and practitioners. Acclarent leverages Johnson & Johnson's extensive distribution network and expertise in medical technology to maintain a competitive edge in the market.
Keywords: ENT solutions, minimally invasive, medical devices, chronic sinusitis, Eustachian tube, healthcare providers, innovation, patient outcomes, surgical procedures, Johnson & Johnson.
Talent graph
Acclarent's talent
Source: Dealroom Talent Intelligence.
Global footprint
Where Acclarent has talent and traffic
team presence
Market sentiment
What the market is saying about Acclarent
An AI-synthesized read of the highest-engagement posts about Acclarent on X over the past 7 days. We rank by likes & retweets, ignore corporate channels, and surface the themes that broke out from real people.
Reading the room on X — pulling top posts and synthesizing themes…
Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour
See Acclarent on the full Dealroom platform
Live deal flow, founder pedigree, hiring signals, revenue trajectory, and the full cap table.





